These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22759349)

  • 1. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
    Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
    J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.
    Allers M; Langejuergen J; Gaida A; Holz O; Schuchardt S; Hohlfeld JM; Zimmermann S
    J Breath Res; 2016 Apr; 10(2):026004. PubMed ID: 27058460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for emphysema via exhaled volatile organic compounds.
    Cristescu SM; Gietema HA; Blanchet L; Kruitwagen CL; Munnik P; van Klaveren RJ; Lammers JW; Buydens L; Harren FJ; Zanen P
    J Breath Res; 2011 Dec; 5(4):046009. PubMed ID: 22071870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
    Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
    Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
    Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
    Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
    Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
    Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification.
    Hauschild AC; Baumbach JI; Baumbach J
    Genet Mol Res; 2012 Aug; 11(3):2733-44. PubMed ID: 22869082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.